Stem Cell Transplantation: Achieving the Best Outcomes for our Patients

Northwest Marrow Transplant Program

Continuing Medical Education

Northwest Marrow Transplant Program
a Collaborative Clinical Program of Legacy Health and OHSU

Friday, April 14, 2017
Multnomah Athletic Club

Experts will share their knowledge of stem cell transplantation, including future horizons for innovative applications of stem cell technology and clinical symptom management challenges.

Topics will include:

  • The current status of transplantation in the treatment of lymphoma.
  • The role of transplantation in the treatment of adult acute lymphocytic leukemia.
  • Diagnosis and management of graft versus host disease.
  • The role of transplantation in the treatment of hemoglobinopathies.
  • Expanding applications for cellular therapy in hematologic malignancy patients.
  • Management of altered mental status during the inpatient treatment phase.

Continuing medical education credit will be available for doctors and continuing education credit for nurses.

Space is limited,
register soon!

Register Online


Cost is $50 for physicians and $25 for nurses and all others. For registration information or questions, call 503-494-8822 or email Barbara Soule: . For course content questions, call 503-494-0532 or email .

Download save-the-date postcard
Download conference brochure and agenda


Speakers

Faculty

Gerald Segal, M.D.
Medical Director, Legacy Good Samaritan Hospital
Autologous Stem Cell Transplantation Program

Richard Maziarz, M.D.
Professor, Division of Hematology and Medical Oncology, OHSU
Director, Adult Bone Marrow Transplant Program, OHSU
Director, Northwest Marrow Transplant Program

Andy Chen, M.D., Ph.D.
Assistant professor, Division of Hematology and Medical Oncology, OHSU
Attending physician, Adult Bone Marrow Transplant Program

Rachel Cook, M.D.
Assistant professor, Division of Hematology and Medical Oncology, OHSU
Attending physician, Adult Bone Marrow Transplant Program

Brandon Hayes-Lattin, M.D.
Associate professor, Division of Hematology and Medical Oncology, OHSU
Attending physician, Adult Bone Marrow Transplant Program

Jessica Leonard, M.D.
Instructor, Division of Hematology and Medical Oncology, OHSU
Attending physician, Adult Bone Marrow Transplant Program

Daniel Weisdorf, M.D.
Professor; Chief, Division of Hematology, Oncology and Transplantation
Director, Adult Bone Marrow Transplant Program
Deputy director, Clinical Translational Science Institute, University of Minnesota

Joseph Bubalo, Pharm.D., B.C.P.S., B.C.O.P.
Assistant professor, OHSU Hospitals and Clinics, Oncology Clinical Pharmacy Specialist, OHSU

Eneida Nemecek, M.D., M.S.
Professor, Division of Pediatric Hematology and Medical Oncology, OHSU
Director, Pediatric Stem Cell Transplant Program, Doernbecher Children’s Hospital

Agenda

Agenda

Friday, April 14, 2017

11:30 a.m. Registration and Lunch

Noon Welcome and Speaker Introductions
Richard Maziarz, M.D.
Gerald Segal, M.D.

12:15 p.m. Updates on the Transplant Community
Rachel Cook, M.D.

12:45 p.m. The Role of Transplant in Adult Acute Lymphoblastic Leukemia
Brandon Hayes-Lattin, M.D.
Jessica Leonard, M.D.

1:30 p.m. Current Status of Transplant in the Treatment of Lymphoma
Andy Chen, M.D., Ph.D.

2:15 p.m. Break

2:30 p.m. Graft Versus Host Disease — Progress In Diagnosis and Management
Daniel Weisdorf, M.D.

3:15 p.m. Altered Mental Status in the Hospitalized Patient: What to Do?
Joseph Bubalo, Pharm.D., B.C.P.S., B .C.O.P.

3:45 p.m. Break

4 p.m. Transplantation for Hemoglobinopathies
Eneida Nemecek, M.D., M.S.

4:30 p.m. Expanding Applications for Cellular Therapy in the Management of Patients with Hematologic Malignancies
Richard Maziarz, M.D.

5:15 p.m. Closing Remarks

Who should attend

Who should attend

This program is intended for adult and pediatric oncologists and hematologists, inpatient and outpatient clinic nurses, health plan medical directors, health plan case management professionals, and other health care professionals with an interest in the role of stem cell transplantation.

Contact and Accreditation

Contact

For more information, please call 503-494-0532 or email

Request reasonable accommodation for this event at 503-494-2834 or

Accreditation and Credit

AMA PRA Category 1 Credit ™ information coming soon for this course.

Nursing credit: This course is approved for 4.5 contact hours through Legacy Health System Patient Care Services. Provider approved by the California Board of Registered Nursing. Provider Number CEP8749.

About the Northwest Marrow Transplant Program

About the Northwest  Marrow Transplant Program

The Northwest Marrow Transplant Program is a collaboration between OHSU and Legacy Health. The program offers every available blood and marrow transplantation procedure to patients from around the region. Transplant services are provided at Legacy Good Samaritan Hospital, OHSU Hospital and OHSU Doernbecher Children’s Hospital.

This OHSU-Legacy Health collaboration pools the expertise of hematologists and oncologists, and gives patients and families more opportunities to benefit from recent advances in stem cell transplantation.

The Northwest Marrow Transplant Program was accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) in December 2000. It was the first multicenter clinical program in the United States to be accredited.